Shares up nearly 5% to $54.22 in early trading Spikevax COVID vaccine sales reached $1.8 billion, beating expectations Moderna expects lower COVID vaccine sales this year compared to 2023 $10 ...

The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.

Moderna’s move into personalised cancer therapy continues to proceed at a rapid pace, with Merck & Co-partnered melanoma vaccine mRNA-4157 heading for a pivotal phase 3 programme after a phase ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

Nov 6 (Reuters) - An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organisations said ...

Former presidential candidate Robert F. Kennedy Jr. said he won’t take away vaccines from people when President-elect Trump takes office in January. Kennedy, who is expected to serve in a second ...

Robert F. Kennedy Jr., who may play a key role overseeing public health issues in a second Trump administration, said Wednesday that he wouldn't “take away anybody's vaccines.” Asked said in ...

Robert F. Kennedy Jr., a vaccine skeptic, said he didn’t plan to take away anybody’s vaccines if given a role in the second Trump administration. President-elect Donald Trump has said Kennedy ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more T-shirts are quintessential for any wardrobe, especially during the spring and summer. They're a ...